iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.16M | -- | -4.36M | -3.99M | -7.78M |
| Total Depreciation and Amortization | 293.00K | -- | 281.00K | 278.00K | 281.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 247.00K | -- | 461.00K | 396.00K | 4.89M |
| Change in Net Operating Assets | 8.00K | -- | -247.00K | -400.00K | -2.25M |
| Cash from Operations | -4.62M | -- | -3.87M | -3.72M | -4.85M |
| Capital Expenditure | -1.00K | -- | -1.00K | -- | -210.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 66.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.00K | -- | -1.00K | 713.00K | 0.00 |
| Cash from Investing | 45.00K | -- | -2.00K | 713.00K | -144.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -183.00K | -- | -170.00K | -166.00K | -1.24M |
| Issuance of Common Stock | 2.41M | -- | 18.00K | 4.00K | 14.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.95M | -- | -- | -- | -88.00K |
| Cash from Financing | 8.18M | -- | -152.00K | -162.00K | 12.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.61M | -- | -4.02M | -3.16M | 7.99M |